Richard Klausner

Insider Reports History

Location
5200 Illumina Way, San Diego, CA
Signature
/s/ Charles Newton, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Klausner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Director Common Stock 2.97M $1.39M $0.47 May 15, 2025 Direct
Lyell Immunopharma, Inc. Director Common Stock 843K $396K $0.47 May 15, 2025 Grantor and Trustee
Lyell Immunopharma, Inc. Director Option (right to buy) 130K May 15, 2025 Direct
Lyell Immunopharma, Inc. Director Option (right to buy) 130K Jun 14, 2024 Direct

Insider Reports Filed by Richard Klausner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LYEL Lyell Immunopharma, Inc. May 15, 2025 1 $0 4 May 19, 2025 Director
LYEL Lyell Immunopharma, Inc. Mar 14, 2025 1 $94.9K 4 Mar 18, 2025 Director
LYEL Lyell Immunopharma, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
LYEL Lyell Immunopharma, Inc. Sep 8, 2023 1 $0 4 Sep 8, 2023 Director
LYEL Lyell Immunopharma, Inc. Aug 15, 2023 1 -$132K 4 Aug 17, 2023 Director
LYEL Lyell Immunopharma, Inc. Jun 16, 2023 1 $0 4 Jun 20, 2023 Director
LYEL Lyell Immunopharma, Inc. Sep 23, 2022 1 -$71K 4 Sep 27, 2022 Director
LYEL Lyell Immunopharma, Inc. Jun 21, 2021 2 $0 4 Jun 23, 2021 Executive Chairman, Director
LYEL Lyell Immunopharma, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Executive Chairman, Director
LYEL Lyell Immunopharma, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2022 Director